About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 435271, 12 pages
http://dx.doi.org/10.1155/2011/435271
Research Article

Facilitated Cross-Bridge Interactions with Thin Filaments by Familial Hypertrophic Cardiomyopathy Mutations in α-Tropomyosin

1Department of Biological Science, The Florida State University, Tallahassee, FL 32306-4295, USA
2Department of Neurobiology, College of Basic Medical Science, Southern Medical University, Guangzhou 510515, China
3Donders Institute for Brain, Cognition and Behavior, Centre for Cognitive Neuroimaging, Radboud University Nijmegen, 6500 HB Nijmegen, The Netherlands
4Department of Biology, American University in Cairo, Cairo 11835, Egypt
5Department of Biomedical Sciences, The Florida State University College of Medicine, Tallahassee, FL 32306, USA
6Institute of Molecular Biophysics, The Florida State University, Tallahassee, FL 32306, USA
7Department of Mathematics, The Florida State University, Tallahassee, FL 32306, USA
8Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA
9QIAGEN Inc., Valencia, CA 91355, USA
10Department of Physics, The Florida State University, Tallahassee, FL 32306, USA
11Hitachi Global Storage Technologies, San Jose Research Center, San Jose, CA 95135, USA
12Agilent Technologies Inc., Santa Clara, CA 95051, USA

Received 1 June 2011; Accepted 24 August 2011

Academic Editor: Guy Benian

Copyright © 2011 Fang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Towbin and N. E. Bowles, “The failing heart,” Nature, vol. 415, no. 6868, pp. 227–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. S. Redwood, J. C. Moolman-Smook, and H. Watkins, “Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy,” Cardiovascular Research, vol. 44, no. 1, pp. 20–36, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Fatkin and R. M. Graham, “Molecular mechanisms of inherited cardiomyopathies,” Physiological Reviews, vol. 82, no. 4, pp. 945–980, 2002. View at Scopus
  4. M. S. Parmacek and R. J. Solaro, “Biology of the troponin complex in cardiac myocytes,” Progress in Cardiovascular Diseases, vol. 47, no. 3, pp. 159–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Ahmad, J. G. Seidman, and C. E. Seidman, “The genetic basis for cardiac remodeling,” Annual Review of Genomics and Human Genetics, vol. 6, pp. 185–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Elliott, H. Watkins, and C. S. Redwood, “Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22069–22074, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Homsher, D. M. Lee, C. Morris, D. Pavlov, and L. S. Tobacman, “Regulation of force and unloaded sliding speed in single thin filaments: effects of regulatory proteins and calcium,” Journal of Physiology, vol. 524, no. 1, pp. 233–243, 2000. View at Scopus
  8. J. Köhler, Y. Chen, B. Brenner et al., “Familial hypertrophic cardiomyopathy mutations in troponin I (K183Δ, G203S, K206Q) enhance filament sliding,” Physiological Genomics, vol. 14, pp. 117–128, 2003. View at Scopus
  9. R. Lang, A. V. Gomes, J. Zhao, P. R. Housmans, T. Miller, and J. D. Potter, “Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 277, no. 14, pp. 11670–11678, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Lin, A. Bobkova, E. Homsher, and L. S. Tobacman, “Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy,” Journal of Clinical Investigation, vol. 97, no. 12, pp. 2842–2848, 1996. View at Scopus
  11. H. L. Sweeney, H. S. Feng, Z. Yang, and H. Watkins, “Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14406–14410, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Szczesna, R. Zhang, J. Zhao, M. Jones, G. Guzman, and J. D. Potter, “Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 275, no. 1, pp. 624–630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Takahashi-Yanaga, S. Morimoto, K. Harada et al., “Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 12, pp. 2095–2107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Thierfelder, H. Watkins, C. MacRae et al., “α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere,” Cell, vol. 77, no. 5, pp. 701–712, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Karibe, L. S. Tobacman, J. Strand et al., “Hypertrophic cardiomyopathy caused by a novel α-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis,” Circulation, vol. 103, no. 1, pp. 65–71, 2001. View at Scopus
  16. A. M. Gordon, Y. Chen, B. Liang, M. LaMadrid, Z. Luo, and P. B. Chase, “Skeletal muscle regulatory proteins enhance F-actin in vitro motility,” Advances in Experimental Medicine and Biology, vol. 453, pp. 187–197, 1998. View at Scopus
  17. P. VanBuren, K. A. Palmiter, and D. M. Warshaw, “Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 22, pp. 12488–12493, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. S. V. Perry, “Vertebrate tropomyosin: distribution, properties and function,” Journal of Muscle Research and Cell Motility, vol. 22, no. 1, pp. 5–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Gordon, E. Homsher, and M. Regnier, “Regulation of contraction in striated muscle,” Physiological Reviews, vol. 80, no. 2, pp. 853–924, 2000. View at Scopus
  20. W. Bing, C. S. Redwood, I. F. Purcell, G. Esposito, H. Watkins, and S. B. Marston, “Effects of two hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility,” Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 760–764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Golitsina, Y. An, N. J. Greenfield et al., “Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function,” Biochemistry, vol. 38, no. 12, p. 3850, 1999. View at Scopus
  22. M. C. Mathur, P. B. Chase, and J. M. Chalovich, “Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin,” Biochemical and Biophysical Research Communications, vol. 406, no. 1, pp. 74–78, 2011. View at Publisher · View at Google Scholar
  23. M. J. Heller, M. Nili, E. Homsher, and L. S. Tobacman, “Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 41742–41748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Kremneva, S. Boussouf, O. Nikolaeva, R. Maytum, M. A. Geeves, and D. I. Levitsky, “Effects of two familial hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glut180Gly, on the thermal unfolding of actin-bound tropomyosin,” Biophysical Journal, vol. 87, no. 6, pp. 3922–3933, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Bai, A. Weis, A. K. Takeda, P. B. Chase, and M. Kawai, “Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations,” Biophysical Journal, vol. 100, no. 4, pp. 1014–1023, 2011. View at Publisher · View at Google Scholar
  26. W. Bing, A. Knott, C. Redwood et al., “Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle α-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 8, pp. 1489–1498, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Bottinelli, D. A. Coviello, C. S. Redwood et al., “A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity,” Circulation Research, vol. 82, no. 1, pp. 106–115, 1998. View at Scopus
  28. R. Prabhakar, N. Petrashevskaya, A. Schwartz et al., “A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation,” Molecular and Cellular Biochemistry, vol. 251, no. 1-2, pp. 33–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Prabhakar, G. P. Boivin, I. L. Grupp et al., “A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 10, pp. 1815–1828, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. P. B. Monteiro, R. C. Lataro, J. A. Ferro, and F. D. C. Reinach, “Functional α-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group,” Journal of Biological Chemistry, vol. 269, no. 14, pp. 10461–10466, 1994. View at Scopus
  31. B. Schoffstall, N. M. Brunet, S. Williams et al., “Ca2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform,” Journal of Physiology, vol. 577, no. 3, pp. 935–944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Gordon, M. A. LaMadrid, Y. Chen, Z. Luo, and P. B. Chase, “Calcium regulation of skeletal muscle thin filament motility in vitro,” Biophysical Journal, vol. 72, no. 3, pp. 1295–1307, 1997. View at Scopus
  33. S. S. Margossian and S. Lowey, “Preparation of myosin and its subfragments from rabbit skeletal muscle,” Methods in Enzymology, vol. 85, pp. 55–71, 1982. View at Publisher · View at Google Scholar · View at Scopus
  34. J. D. Pardee and J. Aspudich, “Purification of muscle actin,” Methods in Enzymology, vol. 85, pp. 164–181, 1982. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Kron, Y. Y. Toyoshima, T. Q. P. Uyeda, and J. A. Spudich, “Assays for actin sliding movement over myosin-coated surfaces,” Methods in Enzymology, vol. 196, pp. 399–416, 1991. View at Scopus
  36. H. Edelhoch, “Spectroscopic determination of tryptophan and tyrosine in proteins,” Biochemistry, vol. 6, no. 7, pp. 1948–1954, 1967. View at Scopus
  37. Y. H. Chen, J. T. Yang, and H. M. Martinez, “Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion,” Biochemistry, vol. 11, no. 22, pp. 4120–4131, 1972. View at Scopus
  38. N. Sreerama and R. W. Woody, “Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set,” Analytical Biochemistry, vol. 287, no. 2, pp. 252–260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. G. C. Chen and J. T. Yang, “Two-point calibration of circular dichrometer with d-10-camphorsulfonic acid,” Analytical Letters, vol. 10, pp. 1195–1207, 1977.
  40. B. Liang, Y. Chen, C. K. Wang et al., “Ca2+ regulation of rabbit skeletal muscle thin filament sliding: role of cross-bridge number,” Biophysical Journal, vol. 85, no. 3, pp. 1775–1786, 2003. View at Scopus
  41. G. Mihajlović, N. M. Brunet, J. Trbović, P. Xiong, S. Von Molnár, and P. B. Chase, “All-electrical switching and control mechanism for actomyosin-powered nanoactuators,” Applied Physics Letters, vol. 85, no. 6, pp. 1060–1062, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. N. M. Brunet, G. Mihajlovi ć, K. Aledealat, et al., “Micro-mechanical thermal assays of Ca2+-regulated thin filament function and modulation by hypertrophic cardiomyopathy mutants of human cardiac troponin,” Journal of Biomedicine and Biotechnology. In press.
  43. E. Homsher, B. Kim, A. Bobkova, and L. S. Tobacman, “Calcium regulation of thin filament movement in an in vitro motility assay,” Biophysical Journal, vol. 70, no. 4, pp. 1881–1892, 1996. View at Scopus
  44. T. Q. P. Uyeda, S. J. Kron, and J. A. Spudich, “Myosin step size estimation from slow sliding movement of actin over low densities of heavy meromyosin,” Journal of Molecular Biology, vol. 214, no. 3, pp. 699–710, 1990. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Harada, K. Sakurada, T. Aoki, D. D. Thomas, and T. Yanagida, “Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay,” Journal of Molecular Biology, vol. 216, no. 1, pp. 49–68, 1990. View at Scopus
  46. I. D. C. Fraser and S. B. Marston, “In vitro motility analysis of actin-tropomyosin regulation by troponin and calcium. The thin filament is switched as a single cooperative unit,” Journal of Biological Chemistry, vol. 270, no. 14, pp. 7836–7841, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Schoffstall, V. A. LaBarbera, N. M. Brunet, et al., “Interaction between troponin and myosin enhances contractile activity of myosin in cardiac muscle,” DNA and Cell Biology. In press.
  48. D. E. Michele, F. P. Albayya, and J. M. Metzger, “Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes,” Nature Medicine, vol. 5, no. 12, pp. 1413–1417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. D. E. Michele, C. A. Gomez, K. E. Hong, M. V. Westfall, and J. M. Metzger, “Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by β-blockade,” Circulation Research, vol. 91, no. 3, pp. 255–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. E. M. Burkart, G. M. Arteaga, M. P. Sumandea, R. Prabhakar, D. F. Wieczorek, and R. J. Solaro, “Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an α-tropomyosin mutation linked to familial hypertrophic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 10, pp. 1285–1293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Wernicke, C. Thiel, C. M. Duja-Isac et al., “α-tropomyosin mutations Asp175 Asn and Glu180 Gly affect cardiac function in transgenic rats in different ways,” American Journal of Physiology, vol. 287, no. 3, pp. R685–R695, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Lupas, M. Van Dyke, and J. Stock, “Predicting coiled coils from protein sequences,” Science, vol. 252, no. 5010, pp. 1162–1164, 1991. View at Scopus
  53. T. L. Daniel, A. C. Trimble, and P. B. Chase, “Compliant realignment of binding sites in muscle: transient behavior and mechanical tuning,” Biophysical Journal, vol. 74, no. 4, pp. 1611–1621, 1998. View at Scopus
  54. D. A. Martyn, P. B. Chase, M. Regnier, and A. M. Gordon, “A simple model with myofilament compliance predicts activation-dependent crossbridge kinetics in skinned skeletal fibers,” Biophysical Journal, vol. 83, no. 6, pp. 3425–3434, 2002. View at Scopus
  55. P. B. Chase, J. M. Macpherson, and T. L. Daniel, “A spatially explicit nanomechanical model of the half-sarcomere: myofilament compliance affects Ca2+-activation,” Annals of Biomedical Engineering, vol. 32, no. 11, pp. 1559–1568, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Kataoka, C. Hemmer, and P. B. Chase, “Computational simulation of hypertrophic cardiomyopathy mutations in Troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i,” Journal of Biomechanics, vol. 40, no. 9, pp. 2044–2052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. A. V. Gomes and J. D. Potter, “Molecular and cellular aspects of troponin cardiomyopathies,” Annals of the New York Academy of Sciences, vol. 1015, pp. 214–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. J. H. Brown, K. H. Kim, G. Jun et al., “Deciphering the design of the tropomyosin molecule,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8496–8501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. W. Lehman, V. Hatch, V. Korman et al., “Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments,” Journal of Molecular Biology, vol. 302, no. 3, pp. 593–606, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Vibert, R. Craig, and W. Lehman, “Steric-model for activation of muscle thin filaments,” Journal of Molecular Biology, vol. 266, no. 1, pp. 8–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Q. P. Uyeda, H. M. Warrick, S. J. Kron, and J. A. Spudich, “Quantized velocities at low myosin densities in an in vitro motility assay,” Nature, vol. 352, no. 6333, pp. 307–311, 1991. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Gafurov, S. Fredricksen, A. Cai, B. Brenner, P. B. Chase, and J. M. Chalovich, “The Δ14 mutation of human cardiac troponin T enhances ATPase activity and alters the cooperative binding of S1-ADP to regulated actin,” Biochemistry, vol. 43, no. 48, pp. 15276–15285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. A. V. Gomes and J. D. Potter, “Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene,” Molecular and Cellular Biochemistry, vol. 263, no. 1, pp. 99–114, 2004. View at Publisher · View at Google Scholar · View at Scopus